from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3740c/-

LFCtreatmentdescriptionclass of inhibitor

0.738

Amikacinug/mL Amikacintranslation

1.097

Cap5-10ug/mL Capreomycintranslation

1.798

Rox10-50 ug/mL Roxithromycintranslation

0.582

SM2-5 ug/mL Streptomycintranslation

2.014

Tet5-10 ug/mL Tetracyclinetranslation

-0.053

Rif0.2-5ug/mL Rifampicintranscription

-0.866

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.544

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.644

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.674

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.126

Clofazimine10-13 ug/mL Clofaziminerespiration

0.176

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.341

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.405

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-2.417

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.849

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.060

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.481

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.674

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.078

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.256

KCN5-20 ug/mL Potassium cyaniderespiration

1.639

NaN30.2-2 mM Sodium aziderespiration

0.534

Nigericin50 uM Nigericinrespiration

-0.395

TRC10-150 ug/mL Triclosanrespiration

-0.788

TRZ10-25 ug/mL Thioridazinerespiration

-0.074

Valinomycin0.5-10 uM Valinomycinrespiration

1.082

ZnSO42 mM ZnSO4respiration

-0.796

menadione6-10 ug/mL Menadionerespiration

0.641

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.608

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.189

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.388

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

2.345

NRP_1Non-replicating persistence stage 1dosRassociated

0.517

Amp0.2mg/mL AmpicillincellWall

-0.127

Cephalexin20-100 ug/mL CephalexincellWall

0.062

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.124

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.219

EMB10-20 ug/mL EthambutolcellWall

0.135

Eta12-40 ug/mL EthionamidecellWall

0.374

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.142

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.324

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.493

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.359

BZA0.12 mg/mL BenzamidearomaticAmides

-0.435

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.129

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.380

H2O24 mM hydrogen peroxideDNAdamaging

-0.396

Levo10 ug/mL LevofloxacinDNAdamaging

0.257

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-2.507

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.111

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.348

UVUV-irradiationDNAdamaging

0.303

ARP41-4 ug/mL Antitubercular compound ARP4?

0.160

Antimycin12.5-50 ug/mL Antimycin A?

0.394

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.123

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.198

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.142

PA8240.2-2 ug/mL PA-824?

0.511

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.200

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.195

Verapamil50 uM Verapamil?

0.322

mercaptoethanol2 mM 2-Mercaptoethanol?

0.978

methoxatin10-20 ug/mL Methoxatin?